金沙娱乐js333.com官方网站__金沙网站大全

krjpencn

金沙娱乐js333.com官方网站

서비스분야

澳门金沙在线娱乐官网
澳门金沙在线娱乐官网

현재 위치: > Services & Solutions > Bioanalytical > Large Molecule Servi...

Medicilon offers comprehensive and FDA/CFDA GLP-compliant bioanalysis services to support preclinical and clinical development for small molecule drugs, biologics, vaccines and biomarkers.


Large molecule drugs bioanalysis service Highlights
  • Established in 2015 with many experienced scientists
  • Comprehensive information management
  • Validated Watson LIMS for sample and data management
  • Operation in Shanghai for global support
Capacity
  • Immunoassay Development and Validation of methods for quantitation of drug substances in biological matrices
  • Protein &Peptide &Antibody Drug Analysis
  • Biomarker Screening&Analysis
  • Immunogenicity (ADA)
  • Vaccine
澳门金沙在线娱乐官网 State-of-the-Art Equipment
  • MSD Sector Imager 6000  
  • MoleculeDevices M2/M4/M5 reader  
  • UV 2600 spectrometer 
  • BioTek ELx405 Select 
  • Hamilton workstation  
Large molecule bioanalysis method development & Validation
  • Development,Transfer, Optimization and Validation of Ligand binding Assay methods for quantitation of drug substances in biological matrices
  • Dozens of bioanalysis methds related to Adalimumab, Bevacizumab, Trastuzumab, Pertuzumab and Antibody Drug Conjugate(ADC) were validated and available for use
  • Quick validation to support potential studies
Protein&Antibody& Peptide Drug Analysis
  • Preclinical and Clinical studies conducted in any countries around the world
  • PK/PD/Immunogenicity
  • BE study
Biomarker Testing
  • Inflammation markers
  • Tumor markers
  • Metabolic Markers
  • Cardiovascular markers
  • Bone markers
Vaccine Study
  • Single&Multi-valent vaccine
  • Multi-serotypes antibody assay
  • High through-put&automation
Immunogenicity(ADA) js333.com
  • Screening
  • Confirmatory
  • Titration

관련 실험실

金沙网站大全